Telomeres are highly repeated DNA sequences that stop chromosome ends from fraying. They shorten as we age, making them markers of biological aging. In this study, we employed an innovative approach to estimate leukocyte telomere length (LTL) through the utilization of the bioinformatics tool TelSeq, leveraging existing whole-genome sequencing data sourced from the Department of Veteran Affairs' Million Veteran Program (MVP) encompassing a cohort of 102,646 diverse individuals. Using the TelSeq-estimated LTL, we conducted parametric and non-parametric statistical analyses with demographic descriptors such as age, sex, and genetically inferred ancestry (GIA). Our results revealed a near-linear yet modest inverse correlation between age and LTL (r;= -0.20, p < 1E-300). Specifically, each year increase in age corresponded to an 8bp LTL decrease (p < 1E-300) after adjusting for sex and GIA groups. Females had longer LTL than males, even after controlling for ancestry and age (b = 58 bp, p < 1E-300). Additionally, differences in LTL were observed among ancestry groups (Median LTLAfrican = 2.03kb, Median LTLEuropean = 2.01kb, Median LTLAdmixedAmerican = 2.00kb), however, these differences were not statistically significant between the two largest groups - African and European ancestry. To validate TelSeq-estimated LTL, we utilized methylation profiles of 140 cytosine-phosphate-guanine dinucleotides (CpGs) on 28,669 individuals to derive DNA methylation-based telomere length estimator (DNAmTL). DNAmTL had a modest correlation with TelSeq-estimated LTL (b=0.21, p < 1E-300). Consistent with Telseq-estimated LTL, DNAmTL was inversely associated with age where each year increase corresponded to 16bp DNAmTL decrease (p < 1E-300) after adjusting for sex and GIA groups. After controlling for these parameters, males were also found to exhibit shorter DNAmTL than females (b = -98 bp, p < 1E-300), similar to observations from TelSeq-estimated LTL. Lastly, individuals of African and Admixed-American ancestry had longer DNAmTL than those of European ancestry.

The authors have declared no competing interest.

This research is based on data from the Million Veteran Program, Office of Research and Development, Veterans Health Administration, and was supported by Award #000.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors